Can DLBCL be kept under control even if complete recovery isn't possible, and what is the risk of death?
Yes, DLBCL can sometimes be managed even without complete recovery. About 20 percent of people achieve partial response to initial treatment, meaning the disease is controlled but not completely eliminated Show Full Answer
Can DLBCL be kept under control even if complete recovery isn't possible, and what is the risk of death?
Yes, DLBCL can sometimes be managed even without complete recovery. About 20 percent of people achieve partial response to initial treatment, meaning the disease is controlled but not completely eliminated. Additionally, if DLBCL relapses after initial treatment, second-line therapies can help achieve remission again—about 44 percent of people who relapse respond to second-line treatment.
Treatment options for managing DLBCL that hasn't completely responded include:
- Second-line chemotherapy drugs
- CAR T-cell therapy
- Bone marrow transplant
- Bispecific antibodies
- Clinical trials for new therapies
Some people experience cycles of treatment, improvement, and relapse, but continued management is possible. Regarding survival, the five-year relative survival rate for DLBCL is about 65 percent overall. This means roughly 65 out of 100 people with DLBCL are alive five years after diagnosis.
Survival rates vary significantly based on:
- Stage at diagnosis (stage 1 has 79.2% five-year survival, stage 2 has 75.5%)
- Response to treatment (those achieving complete response have better outcomes)
- Age and overall health
People who achieve complete response after initial treatment have the best prognosis—about 80 percent live at least five years. Early diagnosis and prompt treatment are critical for improving survival chances.
December 30, 2025
Join
Your Privacy Choices
